Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2024 | 1092 | 1.010 |
Why?
|
| Vitis | 7 | 2019 | 37 | 0.980 |
Why?
|
| Plant Extracts | 7 | 2019 | 302 | 0.800 |
Why?
|
| Isothiocyanates | 2 | 2012 | 20 | 0.590 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2018 | 4 | 0.570 |
Why?
|
| Annexin A2 | 1 | 2018 | 6 | 0.570 |
Why?
|
| Chaperonin 60 | 1 | 2018 | 15 | 0.560 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 118 | 0.520 |
Why?
|
| Cell-Matrix Junctions | 1 | 2012 | 2 | 0.370 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 1 | 2012 | 13 | 0.370 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2012 | 29 | 0.370 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2012 | 29 | 0.360 |
Why?
|
| Stilbenes | 2 | 2008 | 44 | 0.330 |
Why?
|
| Selenoproteins | 1 | 2012 | 155 | 0.320 |
Why?
|
| Anticarcinogenic Agents | 3 | 2015 | 77 | 0.260 |
Why?
|
| Transcription Factors | 3 | 2019 | 735 | 0.260 |
Why?
|
| Chemoprevention | 2 | 2015 | 41 | 0.250 |
Why?
|
| Dietary Fiber | 1 | 2006 | 51 | 0.250 |
Why?
|
| Diet Records | 1 | 2006 | 58 | 0.250 |
Why?
|
| Nutrition Assessment | 1 | 2006 | 80 | 0.240 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 100 | 0.220 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2024 | 5 | 0.220 |
Why?
|
| Carcinogens | 1 | 2005 | 126 | 0.210 |
Why?
|
| Antigens, Surface | 1 | 2024 | 52 | 0.210 |
Why?
|
| Glutathione | 1 | 2005 | 171 | 0.210 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 934 | 0.190 |
Why?
|
| Disease Progression | 2 | 2018 | 667 | 0.190 |
Why?
|
| Cell Proliferation | 2 | 2008 | 1455 | 0.180 |
Why?
|
| Caspase 3 | 2 | 2018 | 227 | 0.160 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2015 | 134 | 0.160 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 374 | 0.160 |
Why?
|
| Mice, Nude | 3 | 2024 | 408 | 0.160 |
Why?
|
| Mice | 6 | 2024 | 6644 | 0.150 |
Why?
|
| Cathepsin L | 2 | 2019 | 15 | 0.150 |
Why?
|
| CCAAT-Binding Factor | 1 | 2019 | 3 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 1596 | 0.150 |
Why?
|
| Male | 11 | 2024 | 23409 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2024 | 460 | 0.140 |
Why?
|
| Indans | 1 | 2018 | 14 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 3 | 2024 | 694 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 121 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 150 | 0.140 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1285 | 0.140 |
Why?
|
| Piperidines | 1 | 2018 | 83 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 347 | 0.130 |
Why?
|
| Humans | 14 | 2024 | 43102 | 0.130 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 2676 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2019 | 273 | 0.120 |
Why?
|
| Animals | 7 | 2024 | 16992 | 0.120 |
Why?
|
| Ethanol | 1 | 2018 | 224 | 0.120 |
Why?
|
| Autophagy | 1 | 2016 | 140 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 269 | 0.110 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 49 | 0.110 |
Why?
|
| Apoptosis | 5 | 2019 | 1568 | 0.100 |
Why?
|
| Superoxides | 1 | 2014 | 57 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 154 | 0.100 |
Why?
|
| Genotype | 2 | 2017 | 800 | 0.100 |
Why?
|
| Neoplasms | 1 | 2005 | 1377 | 0.100 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2012 | 5 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 43 | 0.090 |
Why?
|
| Selenocysteine | 1 | 2012 | 58 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 62 | 0.090 |
Why?
|
| Cell Survival | 2 | 2019 | 945 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2012 | 1035 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 968 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 21 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 20 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 106 | 0.070 |
Why?
|
| Seeds | 1 | 2007 | 46 | 0.070 |
Why?
|
| Nutritional Sciences | 1 | 2006 | 25 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1869 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 508 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 200 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 185 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2006 | 224 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 1019 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 2853 | 0.060 |
Why?
|
| Colonic Polyps | 1 | 2006 | 71 | 0.060 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2005 | 12 | 0.060 |
Why?
|
| Glutathione Reductase | 1 | 2005 | 19 | 0.060 |
Why?
|
| Educational Status | 1 | 2006 | 339 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 611 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 90 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 112 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2005 | 168 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2005 | 69 | 0.050 |
Why?
|
| Aged | 3 | 2017 | 8214 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1124 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1723 | 0.050 |
Why?
|
| Cell Movement | 2 | 2019 | 655 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2015 | 2157 | 0.050 |
Why?
|
| Zebrafish | 1 | 2024 | 146 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1081 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2006 | 469 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2005 | 223 | 0.050 |
Why?
|
| Female | 3 | 2015 | 24698 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 532 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 1410 | 0.040 |
Why?
|
| Middle Aged | 3 | 2017 | 12222 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 2018 | 42 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 195 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2018 | 136 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 152 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2017 | 140 | 0.030 |
Why?
|
| Rats | 1 | 2005 | 3735 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 158 | 0.030 |
Why?
|
| Caspase 12 | 1 | 2016 | 5 | 0.030 |
Why?
|
| Chloroquine | 1 | 2016 | 19 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 436 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2016 | 76 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 526 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 57 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 592 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 256 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 152 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2015 | 16 | 0.030 |
Why?
|
| Osteoclasts | 1 | 2015 | 28 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2015 | 19 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2015 | 57 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 51 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 456 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 102 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 241 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 290 | 0.030 |
Why?
|
| Proteomics | 1 | 2016 | 378 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 536 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 1067 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1759 | 0.020 |
Why?
|
| Adult | 1 | 2006 | 13872 | 0.020 |
Why?
|
| Metribolone | 1 | 2008 | 3 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2008 | 28 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 98 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 129 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 310 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 652 | 0.020 |
Why?
|
| Estradiol | 1 | 2008 | 268 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 704 | 0.010 |
Why?
|